Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial

Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial

Guardado en:
Detalles Bibliográficos
Autores principales: Nicolas Penel, Ulrich Keilholz, Ani Balmanoukian, Manish R Patel, Sanjay Goel, Keun-Wook Lee, Alain Mita, Christophe Le Tourneau, Deborah J Wong, Patrick Schöffski, Marcis Bajars, Amaury Daste, Hans Juergen Grote, Dongli Zhou, Michael S Gordon, Martin Gutierrez, Damien Vansteene, Joël Guigay
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/97c536fe1ca34848aead523f055e6235
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:97c536fe1ca34848aead523f055e6235
record_format dspace
spelling oai:doaj.org-article:97c536fe1ca34848aead523f055e62352021-11-28T01:30:07ZAvelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial10.1136/jitc-2021-0029982051-1426https://doaj.org/article/97c536fe1ca34848aead523f055e62352021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e002998.fullhttps://doaj.org/toc/2051-1426Nicolas PenelUlrich KeilholzAni BalmanoukianManish R PatelSanjay GoelKeun-Wook LeeAlain MitaChristophe Le TourneauDeborah J WongPatrick SchöffskiMarcis BajarsAmaury DasteHans Juergen GroteDongli ZhouMichael S GordonMartin GutierrezDamien VansteeneJoël GuigayBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Nicolas Penel
Ulrich Keilholz
Ani Balmanoukian
Manish R Patel
Sanjay Goel
Keun-Wook Lee
Alain Mita
Christophe Le Tourneau
Deborah J Wong
Patrick Schöffski
Marcis Bajars
Amaury Daste
Hans Juergen Grote
Dongli Zhou
Michael S Gordon
Martin Gutierrez
Damien Vansteene
Joël Guigay
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
format article
author Nicolas Penel
Ulrich Keilholz
Ani Balmanoukian
Manish R Patel
Sanjay Goel
Keun-Wook Lee
Alain Mita
Christophe Le Tourneau
Deborah J Wong
Patrick Schöffski
Marcis Bajars
Amaury Daste
Hans Juergen Grote
Dongli Zhou
Michael S Gordon
Martin Gutierrez
Damien Vansteene
Joël Guigay
author_facet Nicolas Penel
Ulrich Keilholz
Ani Balmanoukian
Manish R Patel
Sanjay Goel
Keun-Wook Lee
Alain Mita
Christophe Le Tourneau
Deborah J Wong
Patrick Schöffski
Marcis Bajars
Amaury Daste
Hans Juergen Grote
Dongli Zhou
Michael S Gordon
Martin Gutierrez
Damien Vansteene
Joël Guigay
author_sort Nicolas Penel
title Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
title_short Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
title_full Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
title_fullStr Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
title_full_unstemmed Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
title_sort avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase ib results from the javelin solid tumor trial
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/97c536fe1ca34848aead523f055e6235
work_keys_str_mv AT nicolaspenel avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT ulrichkeilholz avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT anibalmanoukian avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT manishrpatel avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT sanjaygoel avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT keunwooklee avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT alainmita avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT christopheletourneau avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT deborahjwong avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT patrickschoffski avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT marcisbajars avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT amaurydaste avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT hansjuergengrote avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT donglizhou avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT michaelsgordon avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT martingutierrez avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT damienvansteene avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
AT joelguigay avelumabforplatinumineligiblerefractoryrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckphaseibresultsfromthejavelinsolidtumortrial
_version_ 1718408454789398528

Ejemplares similares